397 related articles for article (PubMed ID: 10814729)
1. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
Tershner SA; Helmstetter FJ
Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.
Kow LM; Commons KG; Ogawa S; Pfaff DW
Brain Res; 2002 May; 935(1-2):87-102. PubMed ID: 12062477
[TBL] [Abstract][Full Text] [Related]
3. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
4. Antinociception following application of DAMGO to the basolateral amygdala results from a direct interaction of DAMGO with Mu opioid receptors in the amygdala.
Shin MS; Helmstetter FJ
Brain Res; 2005 Dec; 1064(1-2):56-65. PubMed ID: 16289487
[TBL] [Abstract][Full Text] [Related]
5. Highly delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO.
Hirakawa N; Tershner SA; Fields HL
Neuroreport; 1999 Oct; 10(15):3125-9. PubMed ID: 10574547
[TBL] [Abstract][Full Text] [Related]
6. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
7. Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala.
Finnegan TF; Chen SR; Pan HL
J Pharmacol Exp Ther; 2005 Feb; 312(2):441-8. PubMed ID: 15388784
[TBL] [Abstract][Full Text] [Related]
8. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla.
Helmstetter FJ; Tershner SA; Poore LH; Bellgowan PS
Brain Res; 1998 Jan; 779(1-2):104-18. PubMed ID: 9473612
[TBL] [Abstract][Full Text] [Related]
9. Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons.
Budai D; Fields HL
J Neurophysiol; 1998 Feb; 79(2):677-87. PubMed ID: 9463431
[TBL] [Abstract][Full Text] [Related]
10. Mu- and delta-opioid receptor mRNAs are expressed in periaqueductal gray neurons projecting to the rostral ventromedial medulla.
Wang H; Wessendorf MW
Neuroscience; 2002; 109(3):619-34. PubMed ID: 11823071
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartate receptor agonism and antagonism within the amygdaloid central nucleus suppresses pain affect: differential contribution of the ventrolateral periaqueductal gray.
Spuz CA; Tomaszycki ML; Borszcz GS
J Pain; 2014 Dec; 15(12):1305-18. PubMed ID: 25261341
[TBL] [Abstract][Full Text] [Related]
12. Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat.
Hurley RW; Banfor P; Hammond DL
Neuroscience; 2003; 118(3):789-96. PubMed ID: 12710986
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced release of neurotensin in the periaqueductal gray matter of freely moving rats.
Stiller CO; Gustafsson H; Fried K; Brodin E
Brain Res; 1997 Nov; 774(1-2):149-58. PubMed ID: 9452203
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway.
Xu W; Lundeberg T; Wang YT; Li Y; Yu LC
Neuroscience; 2003; 118(4):1015-22. PubMed ID: 12732246
[TBL] [Abstract][Full Text] [Related]
15. Endogenous opioids acting at a medullary mu-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray.
Roychowdhury SM; Fields HL
Neuroscience; 1996 Oct; 74(3):863-72. PubMed ID: 8884782
[TBL] [Abstract][Full Text] [Related]
16. An electrophysiological characterization of the projection from the central nucleus of the amygdala to the periaqueductal gray of the rat: the role of opioid receptors.
da Costa Gomez TM; Behbehani MM
Brain Res; 1995 Aug; 689(1):21-31. PubMed ID: 8528703
[TBL] [Abstract][Full Text] [Related]
17. Analysis of opioid receptor subtype antagonist effects upon mu opioid agonist-induced feeding elicited from the ventral tegmental area of rats.
Lamonte N; Echo JA; Ackerman TF; Christian G; Bodnar RJ
Brain Res; 2002 Mar; 929(1):96-100. PubMed ID: 11852035
[TBL] [Abstract][Full Text] [Related]
18. Opioid receptor internalization contributes to dermorphin-mediated antinociception.
Macey TA; Ingram SL; Bobeck EN; Hegarty DM; Aicher SA; Arttamangkul S; Morgan MM
Neuroscience; 2010 Jun; 168(2):543-50. PubMed ID: 20394808
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic mechanisms in periaqueductal gray-mediated antinociception.
Tobaldini G; Reis RA; Sardi NF; Lazzarim MK; Tomim DH; Lima MMS; Fischer L
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):225-233. PubMed ID: 29035918
[TBL] [Abstract][Full Text] [Related]
20. Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus.
Osaki MY; Castellan-Baldan L; Calvo F; Carvalho AD; Felippotti TT; de Oliveira R; Ubiali WA; Paschoalin-Maurin T; Elias-Filho DH; Motta V; da Silva LA; Coimbra NC
Brain Res; 2003 Dec; 992(2):179-92. PubMed ID: 14625057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
